I. - Basic information

I.1 - Surname

Jasenovec

I.2 - Name

Tomáš

I.3 - Degrees

MD., PhD.

I.4 - Year of birth

1991

I.5 - Name of the workplace

Univerzita Komenského v Bratislave, Lekárska fakulta, Fyziologický ústav

I.6 - Address of the workplace

Špitálska 24, 813 72 Bratislava

I.7 - Position

Researcher

I.8 - E-mail address

tomas.jasenovec@fmed.uniba.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://www.portalvs.sk/regzam/detail/34279

I.10 - Name of the study field in which a person works at the university

Normal and Pathological Physiology

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.a - Name of the university or institution

Comenius University in Bratislava, Faculty of Medicine

II.b - Year

2017

II.c - Study field and programme

General Medicine

II.3 - Third degree of higher education

II.a - Name of the university or institution

Comenius University in Bratislava, Faculty of Medicine

II.b - Year

2021

II.c - Study field and programme

Normal and Pathological Physiology

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
Researcher	Comenius University in Bratislava, Faculty of Medicine	2021 - till now

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
Physiology	General Medicine	I. + II.	General Medicine

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.a - Bachelor's (first degree)

V.4.b - Diploma (second degree)

V.4.c - Dissertation (third degree)

V.4.2 - Number of defended theses

V.4.a - Bachelor's (first degree)

V.4.b - Diploma (second degree)

V.4.c - Dissertation (third degree)

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

18 Web of Science / 16 Scopus

VI.1.b - Over the last six years

18 Web of Science / 15 Scopus

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

74 Web of Science / 49 Scopus

VI.1.b - Over the last six years

74 Web of Science / 49 Scopus

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

Oleksa V, Bernátová I, Patsula V, Líšková S, Bališ P, Radošinská J, Mičurová A, Kluknavský M,

Jasenovec T, Radošinská D, Macková H, Horák D. Poly(ethylene glycol)-Alendronate-Coated Magnetite

Nanoparticles Do Not Alter Cardiovascular Functions and Red Blood Cells' Properties in Hypertensive Rats.

Nanomaterials (Basel). 2021 May 7;11(5):1238. doi: 10.3390/nano11051238. Q1, IF = 5,719

Radosinska D, Jasenovec T, Golianova A, Szadvari I, Vazan R, Kovacicova I, Snurikova D, Vrbjar N,

Radosinska J. Controlled Coffee Intake Enhances Erythrocyte Deformability, Na,K-ATPase Activity, and

GSH/GSSG Ratio in Healthy Young Adults. Biomedicines. 2024 Nov 9;12(11):2570. doi:

10.3390/biomedicines12112570. Q1, IF = 3,9

Jasenovec T, Radosinska D, Kollarova M, Vrbjar N, Balis P, Trubacova S, Paulis L, Tothova L, Shawkatova

I, Radosinska J. Monocrotaline-Induced Pulmonary Arterial Hypertension and Bosentan Treatment in Rats:

Focus on Plasma and Erythrocyte Parameters. Pharmaceuticals (Basel). 2022 Oct 5;15(10):1227. doi:

10.3390/ph15101227.Q1, IF = 4,6

Radosinska J, Kollarova M, Jasenovec T, Radosinska D, Vrbjar N, Balis P, Puzserova A. Aging in

Normotensive and Spontaneously Hypertensive Rats: Focus on Erythrocyte Properties. Biology (Basel).

2023 Jul 21;12(7):1030. doi: 10.3390/biology12071030. Q1, IF = 3,6

Jasenovec T, Radosinska D, Kollarova M, Balis P, Dayar E, Bernatova I, Zorad S, Vrbjar N, Cacanyova S, Radosinska J. Angiotensin System Modulations in Spontaneously Hypertensive Rats and Consequences on Erythrocyte Properties; Action of MLN-4760 and Zofenopril. Biomedicines. 2021 Dec 14;9(12):1902. doi: 10.3390/biomedicines9121902. IF 6,1 Q1

VI.3 - The most significant research/artistic/other outputs over the last six years

Jasenovec T, Radosinska D, Jansakova K, Kopcikova M, Tomova A, Snurikova D, Vrbjar N,R adosinska J.

Alterations in Antioxidant Status and Erythrocyte Properties in Children with Autism Spectrum Disorder.

Antioxidants (Basel). 2023 Nov 28;12(12):2054. doi: 10.3390/antiox12122054. Q1, IF = 6

Jasenovec T, Radosinska D, Belica I, Raskova B, Puzserova A, Vrbjar N, Radosinska J. Examining Erythrocytes as Potential Blood Biomarkers for Autism Spectrum Disorder: Their Relationship to Symptom Severity and Adaptive Behavior. Biomedicines. 2024 Nov 15;12(11):2619. doi: 10.3390/biomedicines12112619. Q1, IF = 3,9

Vrbjar N, Jasenovec T, Kollarova M, Snurikova D, Chomova M, Radosinska D, Shawkatova I, Tothova L, Radosinska J. Na,K-ATPase Kinetics and Oxidative Stress in Kidneys of Zucker Diabetic Fatty (fa/fa) Rats Depending on the Diabetes Severity-Comparison with Lean (fa/+) and Wistar Rats. Biology (Basel). 2022 Oct 17;11(10):1519. doi: 10.3390/biology11101519. Q1, IF = 5,9

Jasenovec T, Radosinska D, Kollarova M, Balis P, Zorad S, Vrbjar N, Bernatova I, Cacanyiova S, Tothova L, Radosinska J. Effects of Taxifolin in Spontaneously Hypertensive Rats with a Focus on Erythrocyte Quality. Life (Basel). 2022 Dec 7;12(12):2045. doi: 10.3390/life12122045. IF = 3,2, Q2

Jasenovec T, Radosinska D, Kollarova M, Balis P, Ferenczyova K, Kalocayova B, Bartekova M, Tothova L, Radosinska J. Beneficial Effect of Quercetin on Erythrocyte Properties in Type 2 Diabetic Rats. Molecules. 2021 Aug 11;26(16):4868. doi: 10.3390/molecules26164868. IF 4,4, Q1

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

Ferenczyova K, Kalocayova B, Kindernay L, Jelemensky M, Balis P, Berenyiova A, Zemancikova A,

Farkasova V, Sykora M, Tothova L, Jasenovec T, Radosinska J, Torok J, Cacanyiova S, Barancik M,

Bartekova M. Quercetin Exerts Age-Dependent Beneficial Effects on Blood Pressure and Vascular Function,

But Is Inefficient in Preventing Myocardial Ischemia-Reperfusion Injury in Zucker Diabetic Fatty Rats.

Molecules. 2020 Jan 2;25(1):187. doi: 10.3390/molecules25010187. CITATION: Dagher O, Mury P, Thorin-

Trescases N, Noly PE, Thorin E, Carrier M. Therapeutic Potential of Quercetin to Alleviate Endothelial

Dysfunction in Age-Related Cardiovascular Diseases. Front Cardiovasc Med. 2021 Mar 30;8:658400. doi:

10.3389/fcvm.2021.658400

Oleksa V, Bernátová I, Patsula V, Líšková S, Bališ P, Radošinská J, Mičurová A, Kluknavský M, Jasenovec

T, Radošinská D, Macková H, Horák D. Poly(ethylene glycol)-Alendronate-Coated Magnetite Nanoparticles

Do Not Alter Cardiovascular Functions and Red Blood Cells' Properties in Hypertensive Rats.

Nanomaterials (Basel). 2021 May 7;11(5):1238. doi: 10.3390/nano11051238. CITATION: Han X, Tang S,

Wang L, Xu X, Yan R, Yan S, Guo Z, Hu K, Yu T, Li M, Li Y, Zhang F, Gu N. Multicellular Spheroids

Formation on Hydrogel Enhances Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells Under

Magnetic Nanoparticles Induction. Int J Nanomedicine. 2021;16:5101-5115. doi: 10.2147/IJN.S318991

Radosinska J, Jasenovec T, Radosinska D, Balis P, Puzserova A, Skratek M, Manka J, Bernatova I. Ultra-Small Superparamagnetic Iron-Oxide Nanoparticles Exert Different Effects on Erythrocytes in Normotensive and Hypertensive Rats. Biomedicines. 2021 Apr 2;9(4):377. doi: 10.3390/biomedicines9040377.

CITATION: Shi, Z., Dong, J., Tong, W., Yu, P., Liu, Y., & Ban, D. (2024). Biosynthesis of gold nanoparticles by using gelatin as reducing and stabilizing agent under ultrasound irradiation: Application of its catalytic activity and for ameliorating motor recovery after spinal cord injury in the Wistar rat’s model. Inorganic Chemistry Communications.

Jasenovec T, Radosinska D, Kollarova M, Vrbjar N, Balis P, Trubacova S, Paulis L, Tothova L, Shawkatova I, Radosinska J. Monocrotaline-Induced Pulmonary Arterial Hypertension and Bosentan Treatment in Rats: Focus on Plasma and Erythrocyte Parameters. Pharmaceuticals (Basel). 2022 Oct 5;15(10):1227. doi: 10.3390/ph15101227.

CITATION: Panchal J, Jaiswal S, Jain S, Kumawat J, Sharma A, Jain P, Jain S, Verma K, Dwivedi J, Sharma S. Development of novel bosentan analogues as endothelin receptor antagonists for pulmonary arterial hypertension. Eur J Med Chem. 2023 Nov 5;259:115681. doi: 10.1016/j.ejmech.2023.115681.

CITATION: Hu H, Liang W, Ding G. Ion homeostasis in diabetic kidney disease. Trends Endocrinol Metab. 2024 Feb;35(2):142-150. doi: 10.1016/j.tem.2023.09.009.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VEGA 1/0193/21 : Erythrocyte properties and oxidative stress in selected pathologies and after administration of antioxidants

APVV PP-COVID-20-0043 : New perspectives in the treatment of cardiovascular complications associated with COVID-19

APVV-21-0194 : New aspects of cardioprotection by natural antioxidants: role of ageing and lifestyle-related comorbidities

APVV-22-0154 : CARDIOvascular protection mediated by α1AMPK against metabolic syndrome-mediated ENdothelial Dysfunction – identifying new risk factors

APVV 15 -0085: Autism in light of emotional, cognitive and biological contexts.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update

2025-01-31

Name and surname:	MUDr. Tomáš Jasenovec, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava